Xtant Medical


OsteoVive is a next generation viable cell allograft combining osteogenic cells with an osteoconductive, osteoinductive scaffold.  OsteoVive processing preserves a cell population that includes marrow-isolated adult multilineage-inducible (MIAMI) cells. These primitive cells are provided with an osteoinductive scaffold to enhance the patient’s innate healing process. The scaffold is comprised of a proprietary blend of microparticulate cortical, cancellous and demineralized cortical allograft bone in the optimum particle size range of 100-300 microns. OsteoVive is in full compliance with FDA guidelines regarding human cells, tissues and cellular tissue-based products, and is intended for use in bone remodeling.

  • Three dimensional osteoconductive scaffold
  • Osteoinductive potential
  • Viable cells to support osteogenic healing processes
  • Stored and distributed as a frozen product